Padam C. Jain
Central Drug Research Institute
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Padam C. Jain.
European Journal of Pharmacology | 1979
Philip Seeman; Karen Westman; Miroslav Protiva; Jiri Jilek; Padam C. Jain; Anil K. Saxena; Nitya Anand; Leslie G. Humber; Adolf H. Philipp
In order to identify a pair of neuroleptic enantiomers with the highest stereoselective interaction with neuroleptic/dopamine receptors, the effects of eight pairs of neuroleptic enantiomers were tested on the specific binding of 3H-spiperone to crude homogenates of calf caudate nucleus. The ratios of the Ki values were: (+)-butaclamol/(-)-butaclamol = 3000; dexclamol/(-)-analogue = 151; (+)-isobutaclamol/(-)-isobutaclamol = 146; (-)-CTC/(+)-CTC= 109; (-)-centbutindole/(+)-centbutindole = 20; S(+)-octoclothepin/R(-)-octoclothepin = 11. Thus, the neuroleptic receptor is highly stereoselective for the rigid butaclamol derivatives, but much less so for the flexible neuroleptics. The 3H-apomorphine binding site, however, had a stereoselectivity ratio of only 7 for isobutaclamol, further suggesting that the high affinity sites (i.e. nM) for 3H-neuroleptic binding and for 3H-apomorphine binding are different.
Progress in drug research | 1977
Naresh Kumar; Padam C. Jain
Dopamine was long believed to be only of functional significance as a precursor of epinephrine and norepinephrine. It became a focus of interest only after Carlsson’s [1] demonstration of its presence in relatively high concentrations in various parts of the brain, mainly striatum [2] and inner retina [3]. Since then there is a growing evidence of the involvement of dopamine as an important neurotransmitter and of the clinical significance of dopaminergic transmission in CNS. It has been suggested that degeneration of the dopaminergic pathway that connects substantia nigra to the caudate nucleus and putamen is a primary feature in the etiology of Parkinson’s disease [4, 5]. Similarly, dopaminergic system has been implicated in the treatment of schizophrenia with antipsychotic drugs [6]. Dopamine agonists and antagonists are thus antiparkinsonian and antipsychotic drugs, respectively, due to their action on central dopamine receptors [7].
Journal of The Chemical Society D: Chemical Communications | 1971
Padam C. Jain; Yatindra N. Mukerjee; Nitya Anand
In a study of the Diels–Alder reaction of trans,-trans-1,4-diphenylbutadiene with β-nitrostyrenes a marked stereoselectivity to phenyl “endo” adducts has been observed on introduction of electron-withdrawing substituents in the para-position of the phenyl ring of the β-nitrostyrenes.
Journal of Medicinal Chemistry | 1968
Padam C. Jain; V. Kapoor; Nitya Anand; G. K. Patnaik; Allauddin Ahmad; Man M. Vohra
Journal of Medicinal Chemistry | 1973
Anil K. Saxena; Padam C. Jain; Nitya Anand; P. R. Dua
Synthesis | 1976
H. Bhagwatheeswaran; S. P. Gaur; Padam C. Jain
Journal of Medicinal Chemistry | 1970
V. Aruna Rao; Padam C. Jain; Nitya Anand; R. C. Srimal; P. R. Dua
Journal of the American Chemical Society | 1974
Padam C. Jain; Yatindra N. Mukerjee; Nitya Anand
Bioorganic & Medicinal Chemistry | 2003
Anil K. Saxena; Siya Ram; Mridula Saxena; Nidhi Singh; Philip Prathipati; Padam C. Jain; Hemant K. Singh; Nitya Anand
Archiv Der Pharmazie | 1984
Krishna A. Gupta; Anil K. Saxena; Padam C. Jain; Nitya Anand